Table 1.

Therapy courses

DrugDoseDay
12345
Prephase V* Prednisone, orally/iv 30 mg/m2 
 Cyclophosphamide, iv, 1 h 200 mg/m2 x  
Course A Dexamethasone, orally/iv 10 mg/m2 
 Ifosfamide, iv, 1 h 800 mg/m2 
 Methotrexate, iv, 24 h 500 mg/m2     
 Methotrexate, it 12 mg     
 Cytarabine, it 30 mg     
 Prednisolone, it 10 mg     
 Cytarabine, iv, 1 h 150 mg/m2    x x1-153 x x1-153 
 Etoposide, iv, 1 h 100 mg/m2    x  
Course B Dexamethasone, orally/iv 10 mg/m2 
 Cyclophosphamide, iv, 1 h 200 mg/m2 
 Methotrexate, iv, 24 h 500 mg/m2     
 Methotrexate, it 12 mg     
 Cytarabine, it 30 mg     
 Prednisolone, it 10 mg     
 Doxorubicin, iv, 1 h 25 mg/m2    x  
Course AA Dexamethasone, orally/iv 10 mg/m2 
 Ifosfamide, iv, 1 h 800 mg/m2 
 Methotrexate, iv, 24 h1-155 5 g/m2     
 Methotrexate, it 6 mg    x  
 Cytarabine, it 15 mg    x  
 Prednisolone, it 5 mg    x  
 Vincristine, iv 1.5 mg/m21-154     
 Cytarabine, iv, 1 h 150 mg/m2    x x1-153 x x1-153 
 Etoposide, iv, 1 h 100 mg/m2    x  
Course BB Dexamethasone, orally/iv 10 mg/m2 
 Cyclophosphamide, iv, 1 h 200 mg/m2 
 Methotrexate, iv, 24 h1-155 5 g/m2     
 Methotrexate, it 6 mg    x  
 Cytarabine, it 15 mg    x  
 Prednisolone, it 5 mg    x  
 Vincristine, iv 1.5 mg/m21-154     
 Doxorubicin, iv, 1 h 25 mg/m2    x  
Course CC Dexamethasone, orally/iv 20 mg/m2 
 Vindesine, iv 3 mg/m21-154     
 Cytarabine, iv, 3 h 2 g/m2 x x1-153 x x1-153    
 Etoposide, iv, 1 h 150 mg/m2   
 Methotrexate, it 12 mg     
 Cytarabine, it 30 mg     
 Prednisolone, it 10 mg     
DrugDoseDay
12345
Prephase V* Prednisone, orally/iv 30 mg/m2 
 Cyclophosphamide, iv, 1 h 200 mg/m2 x  
Course A Dexamethasone, orally/iv 10 mg/m2 
 Ifosfamide, iv, 1 h 800 mg/m2 
 Methotrexate, iv, 24 h 500 mg/m2     
 Methotrexate, it 12 mg     
 Cytarabine, it 30 mg     
 Prednisolone, it 10 mg     
 Cytarabine, iv, 1 h 150 mg/m2    x x1-153 x x1-153 
 Etoposide, iv, 1 h 100 mg/m2    x  
Course B Dexamethasone, orally/iv 10 mg/m2 
 Cyclophosphamide, iv, 1 h 200 mg/m2 
 Methotrexate, iv, 24 h 500 mg/m2     
 Methotrexate, it 12 mg     
 Cytarabine, it 30 mg     
 Prednisolone, it 10 mg     
 Doxorubicin, iv, 1 h 25 mg/m2    x  
Course AA Dexamethasone, orally/iv 10 mg/m2 
 Ifosfamide, iv, 1 h 800 mg/m2 
 Methotrexate, iv, 24 h1-155 5 g/m2     
 Methotrexate, it 6 mg    x  
 Cytarabine, it 15 mg    x  
 Prednisolone, it 5 mg    x  
 Vincristine, iv 1.5 mg/m21-154     
 Cytarabine, iv, 1 h 150 mg/m2    x x1-153 x x1-153 
 Etoposide, iv, 1 h 100 mg/m2    x  
Course BB Dexamethasone, orally/iv 10 mg/m2 
 Cyclophosphamide, iv, 1 h 200 mg/m2 
 Methotrexate, iv, 24 h1-155 5 g/m2     
 Methotrexate, it 6 mg    x  
 Cytarabine, it 15 mg    x  
 Prednisolone, it 5 mg    x  
 Vincristine, iv 1.5 mg/m21-154     
 Doxorubicin, iv, 1 h 25 mg/m2    x  
Course CC Dexamethasone, orally/iv 20 mg/m2 
 Vindesine, iv 3 mg/m21-154     
 Cytarabine, iv, 3 h 2 g/m2 x x1-153 x x1-153    
 Etoposide, iv, 1 h 150 mg/m2   
 Methotrexate, it 12 mg     
 Cytarabine, it 30 mg     
 Prednisolone, it 10 mg     

iv indicates intravenously; it, intrathecally; h, hour.

*

Amendment July 1993: cyclophosphamide day 1, 2 only, dexamethasone instead of prednisone, see text.

10% of dose within 0.5 h, 90% of dose iv over 23.5 hours, leucovorin rescue 12 mg/m2 iv at hours 48 and 54.

2 hours after beginning of MTX iv infusion, doses were adjusted for children < 3 years of age.

F1-153

12 hours apart.

F1-155

10% of dose within 0.5 hours; 90% iv over 23.5 hours; leucovorin rescue (raceme folinic acid) iv 30 mg/m2 at hour 42; 15 mg/m2 at hours 48 and 54.

F1-154

Maximum dose 2 mg for vincristine, 5 mg/m2 for vindesine.

Close Modal

or Create an Account

Close Modal
Close Modal